-
The nurses' health study reported the risk of invasive breast cancer associated with the use of combined estrogen and testosterone. At the beginning of this cohort study, only 33 women reported testosterone use, but over the next 10 years this number increased to 550.
-
-
The Truth About Multivitamins; Statins and Hepatitis C; Preventing Hot
Flashes; FDA News
-
Anderson and colleagues from the WHI performed subgroup analyses focusing on how prior hormone therapy use influenced the risk of breast cancer found in the estrogen-progestin trial arm.
-
A survey was mailed to 500 members of the American College of Obstetricians and Gynecologists presenting a case of symptomatic fibroids. The respondents were asked to choose hysterectomy or a uterus-sparing procedure, 49% responded.
-
Primary insomnia unrelated to depression is a common and debilitating condition that heightens the risk for accidents, cardiovascular disease, and other long-term health conditions. About 10-25% of adults older than age 54 years report insomnia defined as subjective complaints of poor sleep accompanied by impairment in daytime functioning.
-
-
The incidence of breast cancer increases with age and breast cancer is the most common cancer in women older than 70 years old. In Western countries, approximately 50% of women with breast cancer are older than 65 years old.
-
A popular family of anti-hypertensive medications act by inhibiting angiotensin II converting enzyme. These ACE inhibitors have been implicated as adversely affecting fetal renal function but have generally been ignored as first trimester teratogens.
-
Treating Chronic Primary Insomnia; New Breakthrough in Smoking Cessation?; FDA Actions